[1]申 贵,彭 翔,秦光梅.抗感染督导治疗对脓毒症患者预后影响的研究[J].医学信息,2019,32(01):82-87.[doi:10.3969/j.issn.1006-1959.2019.01.026]
　SHEN Gui,PENG Xiang,QIN Guang-mei.Study on the Effect of Anti-infective Supervision on the Prognosis of Patients with Sepsis[J].Journal of Medical Information,2019,32(01):82-87.[doi:10.3969/j.issn.1006-1959.2019.01.026]
点击复制

抗感染督导治疗对脓毒症患者预后影响的研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年01期
页码:
82-87
栏目:
论著
出版日期:
2019-01-01

文章信息/Info

Title:
Study on the Effect of Anti-infective Supervision on the Prognosis of Patients with Sepsis
文章编号:
1006-1959（2019）01-0082-06
作者:
申 贵; 彭 翔; 秦光梅
重庆医科大学附属永川医院呼吸内科，重庆 402160
Author(s):
SHEN Gui; PENG Xiang; QIN Guang-mei
Department of Respiratory Medicine,Yongchuan Hospital,Chongqing Medical University,Chongqing 402160,China
关键词:
抗感染督导治疗; 脓毒症; 细菌清除率
Keywords:
Anti-infective supervision treatment; Sepsis; Bacterial clearance rate
分类号:
R459.7
DOI:
10.3969/j.issn.1006-1959.2019.01.026
文献标志码:
A
摘要:
目的 观察督导抗感染治疗策略对脓毒症患者预后的影响，为临床提供实用、安全、有效的综合抗感染治疗指导。方法 收集2016年4月~2017年1月在我院呼吸内科住院的脓毒症患者50例，根据随机数字表法分为督导治疗组26例和对照组24例。对照组的患者进行常规治疗，督导治疗组患者接受抗感染方案的监督指导。在患者的病程中记录抗感染治疗后患者的症状变化及抗感染疗效评价，比较两组患者的细菌清除率，抗感染效果评价，7 d及14 d死亡率；入院后第1，2，3，7，14天心肌酶及心肌标志物、血尿素氮及肌酐、凝血功能；入院7 d的液体入量、平均动脉压、降钙素原。结果 两组患者在平均住院时间、平均医疗费用、细菌/真菌检出率，抗生素使用时间、抗菌药物使用强度、7 d及14 d死亡率比较，差异无统计学意义（P＞0.05）。督导治疗组细菌清除率及抗感染有效率均优于对照组（P＜0.05）。督导治疗组患者感染部位依次为肺部73.07%，胆道15.38%，余泌尿系、皮肤、血液占11.55%。最主要的感染部位均为肺部，分别占73.07%及50.00%；细菌培养结果前三位依次铜绿假单胞菌，鲍曼不动杆菌，肺炎克雷伯菌。入院后第1，2，3，7，14天心肌酶、心肌标志物、血尿素氮及肌酐、凝血功能分别比较，差异均无统计学意义（P＞0.05），但督导治疗组恢复较对照组更平稳迅速。两组患者第1，2，3，7天的SOFA评分及7 d液体入量比较，差异无统计学意义（P＞0.05）。两组患者入院治疗24 h后降钙素原比较，差异有统计学意义（P＜0.05），督导治疗组下降更明显。结论 抗感染督导治疗可以有效提高脓毒症患者的细菌清除率及抗感染效果，且患者器官功能恢复更快。
Abstract:
Objective To observe the effect of supervising anti-infective treatment strategy on the prognosis of patients with sepsis, and provide practical, safe and effective comprehensive anti-infective treatment guidance for the clinic. Methods A total of 50 patients with sepsis admitted to our Department of Respiratory Medicine from April 2016 to January 2017 were enrolled. According to the random number table, 26 patients were in the supervision group and 24 patients in the control group. Patients in the control group underwent routine treatment, and patients in the treatment group were supervised and guided by the anti-infective program. In the course of the patient's disease, the patients' symptoms and anti-infective effects were evaluated. The bacterial clearance rate and anti-infective effect were compared between the two groups. The mortality rate was 7 d and 14 d. Myocardial enzymes and myocardial markers, blood urea nitrogen and creatinine, coagulation function on the 1st, 2nd, 3rd, 7th, and 14th d after admission; liquid intake, mean arterial pressure, and procalcitonin at 7 d after admission. Results There were no significant differences in the average length of hospital stay, average medical cost, bacterial/fungus detection rate, antibiotic use time, antibacterial use intensity, and 7 d and 14 d mortality between the two groups (P>0.05). The bacterial clearance rate and anti-infection efficiency of the supervised treatment group were better than those of the control group (P<0.05). In the treatment group, the infection site was 73.07% in the lungs, 15.38% in the biliary tract, and 11.55% in the abdomen, skin and blood. The most important infection sites were lungs, accounting for 73.07% and 50.00%, respectively. The top three bacterial cultures were Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. There were no significant differences in myocardial enzymes, myocardial markers, blood urea nitrogen, creatinine and coagulation between the 1st, 2nd, 3rd, 7th and 14th d after admission (P>0.05), but the control group recovered compared with the control group is more stable and fast. There was no significant difference in SOFA scores and 7 d fluid intake between the two groups on days 1, 2, 3, and 7 (P>0.05). There was a statistically significant difference between the two groups of patients after 24 h of admission to procalcitonin (P<0.05). The decrease in the treatment group was more obvious. Conclusion Anti-infective supervision can effectively improve the bacterial clearance rate and anti-infection effect of patients with sepsis, and the organ function recovery is faster.

参考文献/References:

[1]郑江,郑新川.以细菌主要病原体相关分子为靶标的脓毒症防治策略[J].第三军医大学学报,2016,38(4):323-329.
[2]Murea M,James KM,Russell GB,et al.Risk of catheter-related bloodstream infection in
elderly patients on hemodialysis[J].Clin J Am Soc Nephrol,2014,9(4):764-770.
[3]Castellanos-Ortega A,Suberviola B,García-Astudillo LA, et al.Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients:results of a three-year follow-up quasi-experimental study[J].Critical Care Medicine,2010,39(4):535.
[4]Levy MM,Dellinger RP,Dellinger SR,et al.The Surviving Sepsis Campaign:results of an international guideline-based performance improvement program targeting severe sepsis[J]. Intensive Care Med,2010,36(2):222-231.
[5]王婴云,李浩,周承淳.心肌损伤标志物与脓毒症预后关系的研究[J].临床医学,2014,12(34):58-59.
[6]范泉,张泓.脓毒症患者预后危险因素的Logistic回归分析[J].安微医科大学学报,2014,49(10): 1479-1481.
[7]Hotchkiss RS,Moldawer LL,Opal SM,et al.Sepsis and septic shock[J].Nat Rev Dis Primers, 2016,90(1):199-208.
[8]Horkan CM,Purtle SW,Mendu ML,et al.The association of acute kidney injury in the critically ill and post discharge outcomes:a cohort study[J].Crit Care Med,2015,43(2):354-364.
[9]张海霞,吴先正,杨长清,等.脓毒症患者功能损伤与病情严重程度及预后的相关性研究[J].检验医学与临床,2015,2(12):204-206.
[10]Jong ED,Oers JAV,Beishuizen A,et al.Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients:a randomized,controlled, open-label trial[J].Chinese Journal of Medicine,2016,16(7):819-827.
[11]李华,申亚辉,任冬冬.血清降钙素原和脓毒症患者病原学感染的关系分析[J].2014,43(36):4950- 4952.
[12]赵秀丽,黎明新,王宇.降钙素原、超敏C反应蛋白及白细胞计数在细菌感染性疾病中的诊断价值[J].中国医药指南,2013,11(16):512-514.

相似文献/References:

[1]温占兵.血管生成素-1水平变化预测脓毒症急性肺损伤的价值[J].医学信息,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
　WEN Zhan-bing.The Value of Angiopoietin-1 Level Change in Predicting Acute Lung Injury in Sepsis[J].Journal of Medical Information,2018,31(01):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
[2]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
　ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Journal of Medical Information,2019,32(01):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
[3]杨勋能.参苓白术散对脓毒症患者肠道功能的影响[J].医学信息,2019,32(16):146.[doi:10.3969/j.issn.1006-1959.2019.16.049]
　YANG Xun-neng.Effect of Shenling Baizhu Powder on Intestinal Function in Patients with Sepsis[J].Journal of Medical Information,2019,32(01):146.[doi:10.3969/j.issn.1006-1959.2019.16.049]
[4]杜金洁,胡 鹏.ESKAPE病原菌感染引起脓毒症的研究[J].医学信息,2019,32(21):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
　DU Jin-jie,HU Peng.Study on Sepsis Caused by ESKAPE Pathogen Infection[J].Journal of Medical Information,2019,32(01):33.[doi:10.3969/j.issn.1006-1959.2019.21.012]
[5]刘安平,段海真,汪 松.抗菌肽LL-37的生物学活性及其作用[J].医学信息,2019,32(24):13.[doi:10.3969/j.issn.1006-1959.2019.24.005]
　LIU An-ping,DUAN Hai-zhen,WANG Song.Biological Activity and Effect of Antibacterial Peptide LL-37[J].Journal of Medical Information,2019,32(01):13.[doi:10.3969/j.issn.1006-1959.2019.24.005]
[6]陈冀远.右美托咪啶对脓毒症急性肾损伤患者肾功能及血管紧张素Ⅱ表达的影响[J].医学信息,2020,33(01):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
　CHEN Ji-yuan.Effect of Dexmedetomidine on Renal Function and Angiotensin Ⅱ Expression in Patients with Acute Renal Injury in Sepsis[J].Journal of Medical Information,2020,33(01):142.[doi:10.3969/j.issn.1006-1959.2020.01.045]
[7]赵振宇.miR-33表达与炎症反应的关系[J].医学信息,2020,33(02):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]
　ZHAO Zhen-yu.Relationship Between miR-33 Expression and Inflammatory Response[J].Journal of Medical Information,2020,33(01):73.[doi:10.3969/j.issn.1006-1959.2020.02.020]
[8]石玉英,段训新,黄 龙.老年社区获得性肺炎并脓毒症患者sCD14和CD14+/HLA-DR表达及意义[J].医学信息,2020,33(02):86.[doi:10.3969/j.issn.1006-1959.2020.02.023]
　SHI Yu-ying,DUAN Xun-xin,HUANG Long.Expression and Significance of sCD14 and CD14+/HLA-DR in Elderly Patients with Community Acquired Pneumonia and Sepsis[J].Journal of Medical Information,2020,33(01):86.[doi:10.3969/j.issn.1006-1959.2020.02.023]
[9]陈少忠.IL-6、TNF-α及血磷在老年脓毒症患者中的变化和相关性[J].医学信息,2020,33(05):119.[doi:10.3969/j.issn.1006-1959.2020.05.038]
　CHEN Shao-zhong.Changes and Correlations of IL-6,TNF-α and Blood Phosphorus in Elderly Patients with Sepsis[J].Journal of Medical Information,2020,33(01):119.[doi:10.3969/j.issn.1006-1959.2020.05.038]
[10]周 婷,张青青,刘运安,等.PD-1和IL-35与脓毒症的关系研究[J].医学信息,2020,33(23):27.[doi:10.3969/j.issn.1006-1959.2020.23.009]
　ZHOU Ting,ZHANG Qing-qing,LIU Yun-an,et al.Study on the Relationship Between PD-1 and IL-35 and Sepsis[J].Journal of Medical Information,2020,33(01):27.[doi:10.3969/j.issn.1006-1959.2020.23.009]

更新日期/Last Update: 2019-01-22